31 results on '"Ghielmini, Michele"'
Search Results
2. Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
3. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
4. Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
5. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
6. Choosing wisely in oncology: necessity and obstacles
7. Rituximab maintenance improves overall survival of patients with follicular lymphoma—Individual patient data meta-analysis
8. The 2016 revision of the World Health Organization classification of lymphoid neoplasms
9. How I treat mantle cell lymphoma
10. Patient benefits of maintenance immunotherapy
11. Mantle Cell Lymphoma: New Treatments Targeted to the Biology
12. Weekly x 4 Induction Therapy with the Anti-CD20 Antibody Rituximab: Effect on Circulating t(14;18)+ Follicular Lymphoma Cells
13. Evaluation of the Different Stratification Models for POD24 Prediction in Patients with Follicular Lymphoma
14. A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
15. International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia
16. Plasma Cell Disease Genotyping with the Liquid Biopsy
17. Genotyping of Classical Hodgkin Lymphoma on the Liquid Biopsy
18. Rituximab Maintenance (MR) for Patients with Mantle Cell Lymphoma (MCL) – a Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)
19. The EBMT Lymphoma Working Party-European Mantle Cell Lymphoma Network Consensus Project On The Role Of Autologous and Allogeneic Stem Cell Transplantation In Mantle Cell Lymphoma: Recommendations Applying The Delphi Procedure
20. Histologic Transformation in Marginal Zone Lymphomas
21. Meta Analysis of Grade 3 and/or 4 Toxicities in Low-Grade Non-Hodgkin Lymphoma (LG-NHL) Patients Receiving Maintenance Rituximab (MR) Therapy: Impact of Schedule on Toxicity
22. Central Nervous System (CNS) Relapse In a Population of 143 Patients (Pts) with Mantle Cell Lymphoma (MCL) From Two Centers
23. The Importance of Age in Prognosis of Follicular Lymphoma: Clinical Features and Life Expectancy of Patients Younger Than 40 Years
24. Response: CNS prophylaxis in MCL
25. Meta Analysis: Rituximab as Maintenance Therapy for Patients with Follicular Lymphoma.
26. A Phase I–II Study To Determine the Maximum Tolerated Infusion-Rate of Rituximab, with a Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function.
27. A Multicentre Phase II Trial Testing Gemcitabine in the Treatment of Patients with Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma: SAKK 36/03.
28. Two Phase I Open-Label Studies of the Fully Human HLA-DR-Specific IgG4 Monoclonal Antibody 1D09C3 in Patients with Relapsed and/or Refractory B-Cell Lymphoproliferative Neoplasias on a Weekly and Bi-Weekly Dosing Scheme.
29. High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.
30. Does the FLIPI apply to grade 3 follicular lymphoma?
31. Factors Prognostic for Response and Event Free Survival and Treatment Related Toxicity in 306 Patients with Follicular or Mantle Cell Lymphoma Randomized to Single Agent Rituximab Given at the Standard or at a Prolonged Schedule.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.